ArticleFrontiers in pediatrics2026
Case Report: Gait training using a wearable ankle-exoskeleton in a pediatric patient with Guillain-Barré syndrome.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Guillain-Barré syndrome (GBS) is an acute inflammatory demyelinating polyradiculoneuropathy that can lead to severe gait impairment and functional limitations in pediatric patients. Although conventional physiotherapy (CT) is the standard of care, recovery is often prolonged and characterized by persistent deficits in strength and motor control. Wearable ankle-exoskeletons have emerged as a potential adjunctive tool for task-specific gait training; however, their application in pediatric GBS remains largely unexplored. The aim of this single case report was to describe the clinical application of a structured gait training program using the Biomotum SPARK® wearable ankle-exoskeleton (SPARK®) combined with CT in a pediatric patient with GBS. Results: Discrete variations in muscle strength, spatiotemporal parameters, pelvic kinematics, and muscle activation patterns were recorded between baseline (T0) and post-intervention (T2) assessments. Clinically, manual muscle testing scores suggested localized gains, particularly in bilateral hip abductors (moving from 3/5 to 4/5). Instrumented gait analysis indicated a baseline cadence variation from 101.7 to 108.5 steps/min, alongside a displacement of the gait symmetry index from 1.17% to 0.67%. Pelvic kinematic profiles suggested a trend toward alignment with normative reference bands, notably in pelvic obliquity and right pelvic rotation. Furthermore, surface electromyography recordings suggested localized modifications at T2, characterized by a lower envelope amplitude in the right gastrocnemius medialis activation pattern during the swing-phase (60%-100%) and an increase in amplitude within the normative activation periods of the left tibialis anterior. Conclusions: This single case report describes the clinical application of an integrated gait training protocol using the SPARK®, which was well-tolerated by the pediatric patient during the recovery-phase of GBS. However, these preliminary observations cannot be generalized or attributed solely to the wearable ankle-exoskeleton, as they likely reflect the combined, synergistic influence of spontaneous neurological recovery, conventional rehabilitation, motor learning, and increased walking exposure. Further controlled studies are necessary to evaluate the potential role and efficacy of wearable ankle-exoskeletons in pediatric GBS rehabilitation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.